BPC-157 and peptide stacking: gym hype vs. actual evidence

What did @crazychris actually say?

@crazychris claims that a San Francisco company called "Bay Pride Biotech" developed a peptide called "homo-tide OX" that modulates oxytocin and "amplifies the bonding response when exposed to high testosterone male features." He presents a graph showing a 107% increase in how subjects rated photos of men after one month. He stops short of saying it makes people gay, but then immediately suggests using it to make someone "fall in love with you" by pinning them while they sleep. That last part is not a joke anyone should skip past.

The framing here is equal parts fabricated science and what amounts to advocating for non-consensual drug administration. Let's take both problems seriously.

Does the science back this up?

No. There is no published compound called homo-tide OX, no registered company called Bay Pride Biotech, and no peer-reviewed trial showing any peptide selectively amplifies same-sex attraction. This is fiction dressed up in lab language.

Oxytocin research is real and well-documented. Intranasal oxytocin has been studied for its effects on social bonding, trust, and emotional processing (Heinrichs et al., 2003, Psychoneuroendocrinology). Some studies have shown oxytocin increases in-group favorability and can sharpen attention to emotionally salient faces (Domes et al., 2007, Biological Psychiatry). But none of this literature supports the idea that an oxytocin-modulating compound selectively rewires sexual orientation toward any gender. Sexual orientation involves complex interactions between genetics, neuroanatomy, developmental biology, and lived experience. No single peptide can rewrite that architecture in 30 days. The "107% increase in ratings" graph shown in the video has no verifiable source, no methodology, and no peer review. It is a prop.

What did they get wrong (or right)?

@crazychris got the underlying biology of oxytocin roughly right in the narrow sense. Oxytocin is genuinely involved in trust, attachment, and social bonding. That part checks out at a basic level. Peptides that interact with the oxytocin receptor system are a real area of research.

Everything else is wrong. "Homo-tide OX" does not exist in any published database including PubMed, ClinicalTrials.gov, or the World Health Organization's INN registry. "Bay Pride Biotech" returns no results in SEC filings, California business registries, or biotech directories. The claim that a peptide can increase attraction scores by 107% toward a specific sex in one month has no scientific basis. And the suggestion to administer any compound to someone "while they're sleeping" without their knowledge or consent is not a gray area. That is describing drug-facilitated assault. It does not matter that it was said with a laugh.

What should you actually know?

The real concern here is not just misinformation about peptides. It is that this video uses the aesthetic of legitimate peptide culture, the graph, the clinical language, the "researchers out of" framing, to make a fictional compound sound plausible. That matters because it erodes trust in actual oxytocin research and actual peptide science.

Real oxytocin peptide analogs are being studied for conditions like autism spectrum disorder, post-traumatic stress, and social anxiety (Guastella et al., 2010, Biological Psychiatry). That research is slow, inconclusive in many areas, and nowhere near the "drink this and change who you're attracted to" territory this video implies. If you are curious about peptides that interact with neuroendocrine systems, that is a conversation worth having with a licensed provider, grounded in actual pharmacology, not TikTok theater.

Also worth stating plainly: administering any substance to another person without their knowledge or consent is illegal in every U.S. jurisdiction, regardless of what the substance is.

Is there any broader peptide context worth understanding?

Peptides that modulate hormone-related pathways are a legitimate and growing area of research. Compounds like oxytocin analogs, melanocortin peptides, and neuropeptides are all being investigated for behavioral and endocrine effects. But the standard for claiming a peptide does something specific is peer-reviewed, replicated human trial data, not a bar graph on TikTok from a company that does not appear to exist.

• The #ascend and #bp hashtags suggest this may be targeted at bodybuilding peptide communities where familiarity with compounds like BPC-157 or ipamorelin creates false credibility by association.
• Framing a fake compound alongside real peptide culture is a pattern worth recognizing. It exploits the community's existing openness to novel compounds.
• If a peptide is not listed on PubMed, ClinicalTrials.gov, or in a legitimate pharmacological database, the appropriate default position is skepticism, not experimentation.